Discussion of the “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Lokhnygina Yuliya  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 287-288

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Wassmer Gernot  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 289-291

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Jennison Christopher  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 293-298

Taylor & Francis Ltd

Access to resources Recommend Favorite

George Chi's Discussion of the “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development” By Christy Chuang-Stein, Vladimir Dragalin, Brenda Gaydos, Michael Krams, and José Pinheiro

By Chi George  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 285-286

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Designs in Clinical Drug Development: Opportunities, Challenges, and Scope Reflections Following PhRMA's November 2006 Workshop

By Krams Michael  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 957-964

Taylor & Francis Ltd

Access to resources Recommend Favorite